1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Hemoglobinopathy Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Hydroxyurea 1.2.3 Glutamine 1.2.4 Zynteglo 1.2.5 Other 1.3 Market by Application 1.3.1 Global Hemoglobinopathy Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Sickle Cell Diseases 1.3.3 Thalassemia 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Hemoglobinopathy Drugs Market Perspective (2016-2027) 2.2 Hemoglobinopathy Drugs Growth Trends by Regions 2.2.1 Hemoglobinopathy Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Hemoglobinopathy Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Hemoglobinopathy Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Hemoglobinopathy Drugs Industry Dynamic 2.3.1 Hemoglobinopathy Drugs Market Trends 2.3.2 Hemoglobinopathy Drugs Market Drivers 2.3.3 Hemoglobinopathy Drugs Market Challenges 2.3.4 Hemoglobinopathy Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Hemoglobinopathy Drugs Players by Revenue 3.1.1 Global Top Hemoglobinopathy Drugs Players by Revenue (2016-2021) 3.1.2 Global Hemoglobinopathy Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Hemoglobinopathy Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Hemoglobinopathy Drugs Revenue 3.4 Global Hemoglobinopathy Drugs Market Concentration Ratio 3.4.1 Global Hemoglobinopathy Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Hemoglobinopathy Drugs Revenue in 2020 3.5 Hemoglobinopathy Drugs Key Players Head office and Area Served 3.6 Key Players Hemoglobinopathy Drugs Product Solution and Service 3.7 Date of Enter into Hemoglobinopathy Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Hemoglobinopathy Drugs Breakdown Data by Type 4.1 Global Hemoglobinopathy Drugs Historic Market Size by Type (2016-2021) 4.2 Global Hemoglobinopathy Drugs Forecasted Market Size by Type (2022-2027) 5 Hemoglobinopathy Drugs Breakdown Data by Application 5.1 Global Hemoglobinopathy Drugs Historic Market Size by Application (2016-2021) 5.2 Global Hemoglobinopathy Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Hemoglobinopathy Drugs Market Size (2016-2027) 6.2 North America Hemoglobinopathy Drugs Market Size by Type 6.2.1 North America Hemoglobinopathy Drugs Market Size by Type (2016-2021) 6.2.2 North America Hemoglobinopathy Drugs Market Size by Type (2022-2027) 6.2.3 North America Hemoglobinopathy Drugs Market Size by Type (2016-2027) 6.3 North America Hemoglobinopathy Drugs Market Size by Application 6.3.1 North America Hemoglobinopathy Drugs Market Size by Application (2016-2021) 6.3.2 North America Hemoglobinopathy Drugs Market Size by Application (2022-2027) 6.3.3 North America Hemoglobinopathy Drugs Market Size by Application (2016-2027) 6.4 North America Hemoglobinopathy Drugs Market Size by Country 6.4.1 North America Hemoglobinopathy Drugs Market Size by Country (2016-2021) 6.4.2 North America Hemoglobinopathy Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Hemoglobinopathy Drugs Market Size (2016-2027) 7.2 Europe Hemoglobinopathy Drugs Market Size by Type 7.2.1 Europe Hemoglobinopathy Drugs Market Size by Type (2016-2021) 7.2.2 Europe Hemoglobinopathy Drugs Market Size by Type (2022-2027) 7.2.3 Europe Hemoglobinopathy Drugs Market Size by Type (2016-2027) 7.3 Europe Hemoglobinopathy Drugs Market Size by Application 7.3.1 Europe Hemoglobinopathy Drugs Market Size by Application (2016-2021) 7.3.2 Europe Hemoglobinopathy Drugs Market Size by Application (2022-2027) 7.3.3 Europe Hemoglobinopathy Drugs Market Size by Application (2016-2027) 7.4 Europe Hemoglobinopathy Drugs Market Size by Country 7.4.1 Europe Hemoglobinopathy Drugs Market Size by Country (2016-2021) 7.4.2 Europe Hemoglobinopathy Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Hemoglobinopathy Drugs Market Size (2016-2027) 8.2 Asia-Pacific Hemoglobinopathy Drugs Market Size by Type 8.2.1 Asia-Pacific Hemoglobinopathy Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Hemoglobinopathy Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Hemoglobinopathy Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Hemoglobinopathy Drugs Market Size by Application 8.3.1 Asia-Pacific Hemoglobinopathy Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Hemoglobinopathy Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Hemoglobinopathy Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Hemoglobinopathy Drugs Market Size by Region 8.4.1 Asia-Pacific Hemoglobinopathy Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Hemoglobinopathy Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Hemoglobinopathy Drugs Market Size (2016-2027) 9.2 Latin America Hemoglobinopathy Drugs Market Size by Type 9.2.1 Latin America Hemoglobinopathy Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Hemoglobinopathy Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Hemoglobinopathy Drugs Market Size by Type (2016-2027) 9.3 Latin America Hemoglobinopathy Drugs Market Size by Application 9.3.1 Latin America Hemoglobinopathy Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Hemoglobinopathy Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Hemoglobinopathy Drugs Market Size by Application (2016-2027) 9.4 Latin America Hemoglobinopathy Drugs Market Size by Country 9.4.1 Latin America Hemoglobinopathy Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Hemoglobinopathy Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Hemoglobinopathy Drugs Market Size (2016-2027) 10.2 Middle East & Africa Hemoglobinopathy Drugs Market Size by Type 10.2.1 Middle East & Africa Hemoglobinopathy Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Hemoglobinopathy Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Hemoglobinopathy Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Hemoglobinopathy Drugs Market Size by Application 10.3.1 Middle East & Africa Hemoglobinopathy Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Hemoglobinopathy Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Hemoglobinopathy Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Hemoglobinopathy Drugs Market Size by Country 10.4.1 Middle East & Africa Hemoglobinopathy Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Hemoglobinopathy Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Novartis 11.1.1 Novartis Company Details 11.1.2 Novartis Business Overview 11.1.3 Novartis Hemoglobinopathy Drugs Introduction 11.1.4 Novartis Revenue in Hemoglobinopathy Drugs Business (2016-2021) 11.1.5 Novartis Recent Development 11.2 AstraZeneca 11.2.1 AstraZeneca Company Details 11.2.2 AstraZeneca Business Overview 11.2.3 AstraZeneca Hemoglobinopathy Drugs Introduction 11.2.4 AstraZeneca Revenue in Hemoglobinopathy Drugs Business (2016-2021) 11.2.5 AstraZeneca Recent Development 11.3 Bluebird 11.3.1 Bluebird Company Details 11.3.2 Bluebird Business Overview 11.3.3 Bluebird Hemoglobinopathy Drugs Introduction 11.3.4 Bluebird Revenue in Hemoglobinopathy Drugs Business (2016-2021) 11.3.5 Bluebird Recent Development 11.4 Bristol-Myers Squibb 11.4.1 Bristol-Myers Squibb Company Details 11.4.2 Bristol-Myers Squibb Business Overview 11.4.3 Bristol-Myers Squibb Hemoglobinopathy Drugs Introduction 11.4.4 Bristol-Myers Squibb Revenue in Hemoglobinopathy Drugs Business (2016-2021) 11.4.5 Bristol-Myers Squibb Recent Development 11.5 Emmaus Medical 11.5.1 Emmaus Medical Company Details 11.5.2 Emmaus Medical Business Overview 11.5.3 Emmaus Medical Hemoglobinopathy Drugs Introduction 11.5.4 Emmaus Medical Revenue in Hemoglobinopathy Drugs Business (2016-2021) 11.5.5 Emmaus Medical Recent Development 11.6 Acceleron Pharma 11.6.1 Acceleron Pharma Company Details 11.6.2 Acceleron Pharma Business Overview 11.6.3 Acceleron Pharma Hemoglobinopathy Drugs Introduction 11.6.4 Acceleron Pharma Revenue in Hemoglobinopathy Drugs Business (2016-2021) 11.6.5 Acceleron Pharma Recent Development 11.7 HemaQuest Pharmaceuticals 11.7.1 HemaQuest Pharmaceuticals Company Details 11.7.2 HemaQuest Pharmaceuticals Business Overview 11.7.3 HemaQuest Pharmaceuticals Hemoglobinopathy Drugs Introduction 11.7.4 HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Drugs Business (2016-2021) 11.7.5 HemaQuest Pharmaceuticals Recent Development 11.8 Eli Lilly and Company 11.8.1 Eli Lilly and Company Company Details 11.8.2 Eli Lilly and Company Business Overview 11.8.3 Eli Lilly and Company Hemoglobinopathy Drugs Introduction 11.8.4 Eli Lilly and Company Revenue in Hemoglobinopathy Drugs Business (2016-2021) 11.8.5 Eli Lilly and Company Recent Development 11.9 Celgene 11.9.1 Celgene Company Details 11.9.2 Celgene Business Overview 11.9.3 Celgene Hemoglobinopathy Drugs Introduction 11.9.4 Celgene Revenue in Hemoglobinopathy Drugs Business (2016-2021) 11.9.5 Celgene Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Hemoglobinopathy Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Hydroxyurea Table 3. Key Players of Glutamine Table 4. Key Players of Zynteglo Table 5. Key Players of Other Table 6. Global Hemoglobinopathy Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Hemoglobinopathy Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Hemoglobinopathy Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Hemoglobinopathy Drugs Market Share by Regions (2016-2021) Table 10. Global Hemoglobinopathy Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Hemoglobinopathy Drugs Market Share by Regions (2022-2027) Table 12. Hemoglobinopathy Drugs Market Trends Table 13. Hemoglobinopathy Drugs Market Drivers Table 14. Hemoglobinopathy Drugs Market Challenges Table 15. Hemoglobinopathy Drugs Market Restraints Table 16. Global Hemoglobinopathy Drugs Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Hemoglobinopathy Drugs Market Share by Players (2016-2021) Table 18. Global Top Hemoglobinopathy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathy Drugs as of 2020) Table 19. Ranking of Global Top Hemoglobinopathy Drugs Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Hemoglobinopathy Drugs Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Hemoglobinopathy Drugs Product Solution and Service Table 23. Date of Enter into Hemoglobinopathy Drugs Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Hemoglobinopathy Drugs Market Size by Type (2016-2021) (US$ Million) Table 26. Global Hemoglobinopathy Drugs Revenue Market Share by Type (2016-2021) Table 27. Global Hemoglobinopathy Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Hemoglobinopathy Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Hemoglobinopathy Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Hemoglobinopathy Drugs Revenue Market Share by Application (2016-2021) Table 31. Global Hemoglobinopathy Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Hemoglobinopathy Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Hemoglobinopathy Drugs Market Size by Type (2016-2021) (US$ Million) Table 34. North America Hemoglobinopathy Drugs Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Hemoglobinopathy Drugs Market Size by Application (2016-2021) (US$ Million) Table 36. North America Hemoglobinopathy Drugs Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Hemoglobinopathy Drugs Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Hemoglobinopathy Drugs Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Hemoglobinopathy Drugs Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Hemoglobinopathy Drugs Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Hemoglobinopathy Drugs Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Hemoglobinopathy Drugs Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Hemoglobinopathy Drugs Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Hemoglobinopathy Drugs Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Hemoglobinopathy Drugs Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Hemoglobinopathy Drugs Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Hemoglobinopathy Drugs Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Hemoglobinopathy Drugs Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Hemoglobinopathy Drugs Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Hemoglobinopathy Drugs Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Hemoglobinopathy Drugs Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Hemoglobinopathy Drugs Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Hemoglobinopathy Drugs Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Hemoglobinopathy Drugs Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Hemoglobinopathy Drugs Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Hemoglobinopathy Drugs Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Hemoglobinopathy Drugs Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Hemoglobinopathy Drugs Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Hemoglobinopathy Drugs Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Hemoglobinopathy Drugs Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Hemoglobinopathy Drugs Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Hemoglobinopathy Drugs Market Size by Country (2022-2027) & (US$ Million) Table 63. Novartis Company Details Table 64. Novartis Business Overview Table 65. Novartis Hemoglobinopathy Drugs Product Table 66. Novartis Revenue in Hemoglobinopathy Drugs Business (2016-2021) & (US$ Million) Table 67. Novartis Recent Development Table 68. AstraZeneca Company Details Table 69. AstraZeneca Business Overview Table 70. AstraZeneca Hemoglobinopathy Drugs Product Table 71. AstraZeneca Revenue in Hemoglobinopathy Drugs Business (2016-2021) & (US$ Million) Table 72. AstraZeneca Recent Development Table 73. Bluebird Company Details Table 74. Bluebird Business Overview Table 75. Bluebird Hemoglobinopathy Drugs Product Table 76. Bluebird Revenue in Hemoglobinopathy Drugs Business (2016-2021) & (US$ Million) Table 77. Bluebird Recent Development Table 78. Bristol-Myers Squibb Company Details Table 79. Bristol-Myers Squibb Business Overview Table 80. Bristol-Myers Squibb Hemoglobinopathy Drugs Product Table 81. Bristol-Myers Squibb Revenue in Hemoglobinopathy Drugs Business (2016-2021) & (US$ Million) Table 82. Bristol-Myers Squibb Recent Development Table 83. Emmaus Medical Company Details Table 84. Emmaus Medical Business Overview Table 85. Emmaus Medical Hemoglobinopathy Drugs Product Table 86. Emmaus Medical Revenue in Hemoglobinopathy Drugs Business (2016-2021) & (US$ Million) Table 87. Emmaus Medical Recent Development Table 88. Acceleron Pharma Company Details Table 89. Acceleron Pharma Business Overview Table 90. Acceleron Pharma Hemoglobinopathy Drugs Product Table 91. Acceleron Pharma Revenue in Hemoglobinopathy Drugs Business (2016-2021) & (US$ Million) Table 92. Acceleron Pharma Recent Development Table 93. HemaQuest Pharmaceuticals Company Details Table 94. HemaQuest Pharmaceuticals Business Overview Table 95. HemaQuest Pharmaceuticals Hemoglobinopathy Drugs Product Table 96. HemaQuest Pharmaceuticals Revenue in Hemoglobinopathy Drugs Business (2016-2021) & (US$ Million) Table 97. HemaQuest Pharmaceuticals Recent Development Table 98. Eli Lilly and Company Company Details Table 99. Eli Lilly and Company Business Overview Table 100. Eli Lilly and Company Revenue in Hemoglobinopathy Drugs Business (2016-2021) & (US$ Million) Table 101. Eli Lilly and Company Recent Development Table 102. Celgene Company Details Table 103. Celgene Business Overview Table 104. Celgene Hemoglobinopathy Drugs Product Table 105. Celgene Revenue in Hemoglobinopathy Drugs Business (2016-2021) & (US$ Million) Table 106. Celgene Recent Development Table 107. Research Programs/Design for This Report Table 108. Key Data Information from Secondary Sources Table 109. Key Data Information from Primary Sources List of Figures Figure 1. Global Hemoglobinopathy Drugs Market Share by Type: 2020 VS 2027 Figure 2. Hydroxyurea Features Figure 3. Glutamine Features Figure 4. Zynteglo Features Figure 5. Other Features Figure 6. Global Hemoglobinopathy Drugs Market Share by Application: 2020 VS 2027 Figure 7. Sickle Cell Diseases Case Studies Figure 8. Thalassemia Case Studies Figure 9. Hemoglobinopathy Drugs Report Years Considered Figure 10. Global Hemoglobinopathy Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Hemoglobinopathy Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Hemoglobinopathy Drugs Market Share by Regions: 2020 VS 2027 Figure 13. Global Hemoglobinopathy Drugs Market Share by Regions (2022-2027) Figure 14. Global Hemoglobinopathy Drugs Market Share by Players in 2020 Figure 15. Global Top Hemoglobinopathy Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemoglobinopathy Drugs as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Hemoglobinopathy Drugs Revenue in 2020 Figure 17. Global Hemoglobinopathy Drugs Revenue Market Share by Type (2016-2021) Figure 18. Global Hemoglobinopathy Drugs Revenue Market Share by Type (2022-2027) Figure 19. North America Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Hemoglobinopathy Drugs Market Share by Type (2016-2027) Figure 21. North America Hemoglobinopathy Drugs Market Share by Application (2016-2027) Figure 22. North America Hemoglobinopathy Drugs Market Share by Country (2016-2027) Figure 23. United States Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Hemoglobinopathy Drugs Market Share by Type (2016-2027) Figure 27. Europe Hemoglobinopathy Drugs Market Share by Application (2016-2027) Figure 28. Europe Hemoglobinopathy Drugs Market Share by Country (2016-2027) Figure 29. Germany Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Hemoglobinopathy Drugs Market Share by Type (2016-2027) Figure 37. Asia-Pacific Hemoglobinopathy Drugs Market Share by Application (2016-2027) Figure 38. Asia-Pacific Hemoglobinopathy Drugs Market Share by Region (2016-2027) Figure 39. China Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Hemoglobinopathy Drugs Market Share by Type (2016-2027) Figure 47. Latin America Hemoglobinopathy Drugs Market Share by Application (2016-2027) Figure 48. Latin America Hemoglobinopathy Drugs Market Share by Country (2016-2027) Figure 49. Mexico Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Hemoglobinopathy Drugs Market Share by Type (2016-2027) Figure 53. Middle East & Africa Hemoglobinopathy Drugs Market Share by Application (2016-2027) Figure 54. Middle East & Africa Hemoglobinopathy Drugs Market Share by Country (2016-2027) Figure 55. Turkey Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Hemoglobinopathy Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Novartis Revenue Growth Rate in Hemoglobinopathy Drugs Business (2016-2021) Figure 59. AstraZeneca Revenue Growth Rate in Hemoglobinopathy Drugs Business (2016-2021) Figure 60. Bluebird Revenue Growth Rate in Hemoglobinopathy Drugs Business (2016-2021) Figure 61. Bristol-Myers Squibb Revenue Growth Rate in Hemoglobinopathy Drugs Business (2016-2021) Figure 62. Emmaus Medical Revenue Growth Rate in Hemoglobinopathy Drugs Business (2016-2021) Figure 63. Acceleron Pharma Revenue Growth Rate in Hemoglobinopathy Drugs Business (2016-2021) Figure 64. HemaQuest Pharmaceuticals Revenue Growth Rate in Hemoglobinopathy Drugs Business (2016-2021) Figure 65. Eli Lilly and Company Revenue Growth Rate in Hemoglobinopathy Drugs Business (2016-2021) Figure 66. Celgene Revenue Growth Rate in Hemoglobinopathy Drugs Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Novartis AstraZeneca Bluebird Bristol-Myers Squibb Emmaus Medical Acceleron Pharma HemaQuest Pharmaceuticals Eli Lilly and Company Celgene